Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands.
Department of Cardiology, Princess Alexandra Hospital, The University of Queensland, 199 Ipswich Road, Woolloongabba, Brisbane, Australia, 4102.
Eur J Heart Fail. 2015 Oct;17(10):1042-9. doi: 10.1002/ejhf.297. Epub 2015 Jun 4.
The prognostic implications of anaemia in patients with aortic stenosis (AS) remain unclear. Accordingly, the present study aimed to evaluate the prognostic implications of anaemia in AS patients before and after aortic valve replacement (AVR).
A total of 856 AS patients (age 71 ± 12 years, 60.2% male, 47.4% severe AS) were included. The mean haemoglobin (Hb) level was 13.2 ± 1.8 g/dL, and the prevalence of anaemia (Hb <13.0 g/dL for men, <12.0 g/dL for women) was 32.0%. The prevalence of anaemia rose with increasing severity of AS (28.9% and 35.6% in moderate and severe AS, respectively, P = 0.048) and was independently associated with increased all-cause mortality in severe AS patients whilst under medical therapy [hazard ratio (HR) 2.26, 95% confidence interval (CI) 1.29-3.97, P = 0.005). Similarly, each 1.0 g/dL decrease in Hb was independently associated with increased mortality risk at follow-up (HR 1.35, 95% CI 1.07-1.47, P = 0.006). However, after AVR surgery, severe AS patients who had anaemia had similar long-term survival as patients with normal Hb (log rank P = 0.19). When all AS patients were included and AVR surgery entered as a covariate, anaemia was still independently associated with increased all-cause mortality irrespective of the severity of AS.
A high prevalence of anaemia in moderate and severe AS patients was observed, and its presence was independently associated with increased all-cause mortality. However, after AVR surgery, anaemic patients had similar survival rates as patients with normal Hb.
主动脉瓣狭窄(AS)患者贫血的预后意义尚不清楚。因此,本研究旨在评估 AS 患者主动脉瓣置换术(AVR)前后贫血的预后意义。
共纳入 856 例 AS 患者(年龄 71±12 岁,60.2%为男性,47.4%为重度 AS)。平均血红蛋白(Hb)水平为 13.2±1.8 g/dL,贫血患病率(男性 Hb<13.0 g/dL,女性 Hb<12.0 g/dL)为 32.0%。贫血的患病率随着 AS 严重程度的增加而升高(中度和重度 AS 分别为 28.9%和 35.6%,P=0.048),并且在重度 AS 患者接受药物治疗时与全因死亡率增加独立相关[风险比(HR)2.26,95%置信区间(CI)1.29-3.97,P=0.005]。同样,Hb 每降低 1.0 g/dL,与随访时的死亡风险增加独立相关(HR 1.35,95%CI 1.07-1.47,P=0.006)。然而,在 AVR 手术后,贫血的重度 AS 患者与 Hb 正常的患者具有相似的长期生存率(对数秩检验 P=0.19)。当所有 AS 患者均被纳入且 AVR 手术作为协变量时,贫血与全因死亡率增加仍独立相关,而与 AS 的严重程度无关。
中度和重度 AS 患者贫血的患病率较高,且其存在与全因死亡率增加独立相关。然而,在 AVR 手术后,贫血患者的生存率与 Hb 正常的患者相似。